Last reviewed · How we verify
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke (EXPECT)
The aim is to assess the effects and harms of Xueshuantong lyophilized powder versus placebo in patients with acute ischemic stroke when initiated within 72 hours of symptom onset.
Details
| Lead sponsor | Dongzhimen Hospital, Beijing |
|---|---|
| Phase | PHASE4 |
| Status | UNKNOWN |
| Enrolment | 480 |
| Start date | Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed May 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Ischemic Stroke
Interventions
- Xueshuantong lyophilized powder
- Placebo
- Guidelines-based standard care
Countries
China